FDA approves Gilead’s Veklury for COVID-19 patients with severe renal impairment

Pallavi Madhiraju- July 14, 2023 0

Gilead Sciences said that the US Food and Drug Administration (FDA) has approved a supplemental new drug application (sNDA) for Veklury (remdesivir) usage in COVID-19 ... Read More

Gilead Sciences gets Veklury FDA approval for non-hospitalized Covid-19 patients

pallavi123- January 22, 2022 0

Gilead Sciences has secured expedited approval from the US Food and Drug Administration (FDA) for its nucleotide analog Veklury (remdesivir) for the treatment of non-hospitalized ... Read More

Gilead Sciences bags Remdesivir FDA approval for Covid-19 treatment

pharmanewsdaily- October 24, 2020 0

Remdesivir FDA approval : Gilead Sciences, a California-based biopharma company, has bagged approval from the US Food and Drug Administration (FDA) for its antiviral drug ... Read More

Gilead Sciences announces Veklury EU approval for COVID-19 treatment

pharmanewsdaily- July 6, 2020 0

Veklury EU approval : Gilead Sciences said that Veklury (remdesivir) has been given conditional marketing authorization from the European Commission as a treatment for SARS-CoV-2 ... Read More